Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;16(1):15-23.
doi: 10.1038/s41589-019-0411-6. Epub 2019 Dec 9.

Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex

Affiliations

Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex

Dirksen E Bussiere et al. Nat Chem Biol. 2020 Jan.

Erratum in

Abstract

The anticancer agent indisulam inhibits cell proliferation by causing degradation of RBM39, an essential mRNA splicing factor. Indisulam promotes an interaction between RBM39 and the DCAF15 E3 ligase substrate receptor, leading to RBM39 ubiquitination and proteasome-mediated degradation. To delineate the precise mechanism by which indisulam mediates the DCAF15-RBM39 interaction, we solved the DCAF15-DDB1-DDA1-indisulam-RBM39(RRM2) complex structure to a resolution of 2.3 Å. DCAF15 has a distinct topology that embraces the RBM39(RRM2) domain largely via non-polar interactions, and indisulam binds between DCAF15 and RBM39(RRM2), coordinating additional interactions between the two proteins. Studies with RBM39 point mutants and indisulam analogs validated the structural model and defined the RBM39 α-helical degron motif. The degron is found only in RBM23 and RBM39, and only these proteins were detectably downregulated in indisulam-treated HCT116 cells. This work further explains how indisulam induces RBM39 degradation and defines the challenge of harnessing DCAF15 to degrade additional targets.

PubMed Disclaimer

Comment in

  • Molecular glue concept solidifies.
    Baek K, Schulman BA. Baek K, et al. Nat Chem Biol. 2020 Jan;16(1):2-3. doi: 10.1038/s41589-019-0414-3. Nat Chem Biol. 2020. PMID: 31819271 No abstract available.

References

    1. Bondeson, D. P. & Crew, C. M. Targeted protein degradation by small molecules. Annu. Rev. Pharmacol. Toxicol. 57, 107–123 (2017). - PubMed - DOI
    1. Collins, I., Wang, H., Caldwell, J. J. & Chopra, R. Chemical approaches to targeted protein degradation through modulation of the ubiquitin–proteasome pathway. Biochem. J. 474, 1127–1147 (2017). - PubMed - DOI
    1. Ciechanover, A. Intracellular protein degradation: from a vague Idea, through the lysosome and the ubiquitin–proteasome system, and onto human diseases and drug targeting (Nobel Lecture). Angew. Chem. Int. Ed. 44, 5944–5967 (2005). - DOI
    1. Thrower, J. S. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94–102 (2000). - PubMed - PMC - DOI
    1. Yu, H. & Matouschek, A. Recognition of client proteins by the proteasome. Annu. Rev. Biophys. 46, 149–173 (2017). - PubMed - DOI

MeSH terms